ethylcholine aziridinium has been researched along with scopolamine hydrobromide in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraga, Y; Ikeda, Y; Kobayashi, N; Nakata, N; Ogishima, M; Washizuka, M | 1 |
| Noda, Y; Ochi, Y; Oka, M; Shimada, E | 1 |
| Furuya, Y; Kitajima, I; Ohno, M; Ueki, S; Yamamoto, T; Yatsugi, S | 1 |
| Fisher, A; Hanin, I | 1 |
| Iga, Y; Kawanishi, G; Mizobe, F; Nakahara, N | 1 |
| Furuya, Y; Ueki, S; Yamamoto, T; Yatsugi, S | 1 |
| Endoh, H; Ohyama, M; Okada, M; Sasamata, M; Takahashi, K; Yamamoto, M; Yatsugi, S | 1 |
| Endo, H; Okada, M; Ooyama, M; Ozawa, Y; Tada, S; Yamaguchi, T; Yamamoto, M | 1 |
| Hirai, K; Kato, K; Miyamoto, M; Nagaoka, A; Nishiyama, M; Okada, H; Takahashi, H | 1 |
| Abe, E; Itoh, T; Masuda, Y; Murai, S; Saito, H | 1 |
| Kodama, K; Koga, Y; Shibata, S; Ueki, S; Watanabe, S | 1 |
| Khromova, I; Kraineva, VA; Männistö, PT; Voronina, T; Zolotov, N | 1 |
| Abou-Gharbia, M; Bartolomeo, AC; Boast, CA; Buccafusco, JJ; Husbands, MG; Kille, N; Morris, H; Moyer, JA; Rosenzweig-Lipson, S; Sabb, AL | 1 |
| Kubo, T; Nakamura, S; Nishiike, S; Takeda, N; Uno, A; Yamatodani, A | 1 |
| Kusumoto, H; Minami, A; Shimazu, S; Takahata, K; Yoneda, F | 1 |
| Kolyasnikova, KN; Nazarova, GA; Zolotov, NN | 1 |
1 review(s) available for ethylcholine aziridinium and scopolamine hydrobromide
| Article | Year |
|---|---|
Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
Topics: Aged; Aging; Aluminum; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Haplorhini; Hemicholinium 3; Humans; Neuromuscular Blocking Agents; Neurotoxins; Parasympathetic Nervous System; Scopolamine | 1986 |
15 other study(ies) available for ethylcholine aziridinium and scopolamine hydrobromide
| Article | Year |
|---|---|
Differential effects of intracerebroventricular AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats.
Topics: Animals; Aziridines; Behavior, Animal; Brain; Choline; Choline O-Acetyltransferase; Injections, Intraventricular; Male; Motor Activity; Rats; Rats, Wistar; Scopolamine; Substantia Innominata | 1992 |
Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits.
Topics: Animals; Aziridines; Behavior, Animal; Choline; Indoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Neuromuscular Blocking Agents; Neurons; Parasympathetic Nervous System; Parasympathomimetics; Scopolamine; Serotonin; Serotonin Antagonists | 1991 |
Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
Topics: Animals; Aziridines; Benzoquinones; Brain Ischemia; Choline; Hippocampus; Injections; Male; Memory; Physostigmine; Psychomotor Performance; Pyridazines; Quinones; Rats; Rats, Inbred Strains; Scopolamine; Ubiquinone | 1990 |
Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
Topics: Amnesia; Animals; Arecoline; Aziridines; Choline; Male; Memory; Mice; Mice, Inbred Strains; Oxotremorine; Parasympathomimetics; Quinuclidines; Retention, Psychology; Scopolamine; Thiophenes | 1988 |
A new method for studying working memory by using the three-panel runway apparatus in rats.
Topics: Animals; Aziridines; Choline; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Memory; Neuromuscular Blocking Agents; Rats; Rats, Inbred WKY; Scopolamine | 1988 |
Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in rats.
Topics: Acetylcholine; Animals; Avoidance Learning; Aziridines; Basal Ganglia; Brain Chemistry; Choline; Male; Microdialysis; Morpholines; Motor Activity; Neuromuscular Blocking Agents; Pain Measurement; Parasympathetic Nervous System; Prefrontal Cortex; Rats; Rats, Wistar; Scopolamine | 1994 |
Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats.
Topics: Acetylcholine; Animals; Avoidance Learning; Aziridines; Basal Ganglia; Brain Chemistry; Choline; Dialysis; Male; Morpholines; Motor Activity; Neuromuscular Blocking Agents; Pain; Parasympathetic Nervous System; Rats; Rats, Wistar; Scopolamine; Synaptic Transmission | 1993 |
Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Topics: Amnesia; Animals; Avoidance Learning; Aziridines; Brain; Choline; Delayed-Action Preparations; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Learning; Male; Memory; Mice; Neuromuscular Blocking Agents; Rats; Rats, Wistar; Scopolamine; Thyrotropin-Releasing Hormone | 1993 |
Alpha-sialyl cholesterol reverses AF64A-induced deficit in passive avoidance response and depletion of hippocampal acetylcholine in mice.
Topics: Acetylcholine; Animals; Avoidance Learning; Aziridines; Cholesterol Esters; Choline; Hippocampus; Male; Mice; Mice, Inbred Strains; Motor Activity; Scopolamine; Sialic Acids; Toxins, Biological | 1993 |
Improving effect of acetylcholine receptor agonists on a deficit of 2-deoxyglucose uptake in cerebral cortical and hippocampal slices in aged and AF64A-treated rats.
Topics: Acetylcholine; Aging; Animals; Aziridines; Cerebral Cortex; Cerebral Ventricles; Choline; Deoxyglucose; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Male; Neuromuscular Blocking Agents; Nicotine; Oxotremorine; Parasympathomimetics; Physostigmine; Rats; Rats, Wistar; Receptors, Cholinergic; Scopolamine | 1993 |
Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats.
Topics: Animals; Antiparkinson Agents; Avoidance Learning; Aziridines; Benzophenones; Brain Mapping; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Choline; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extinction, Psychological; Male; Mental Recall; Neural Pathways; Neuromuscular Blocking Agents; Nitriles; Nitrophenols; Rats; Rats, Wistar; Reaction Time; Retention, Psychology; Scopolamine; Substantia Innominata; Tolcapone | 1997 |
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.
Topics: Animals; Aziridines; Behavior, Animal; Brain; Bridged-Ring Compounds; Choline; Choline O-Acetyltransferase; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Female; Frontal Lobe; Hippocampus; Hypothermia; Macaca mulatta; Male; Mice; Muscarinic Agonists; Neuromuscular Blocking Agents; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Salivation; Scopolamine; Thiadiazoles; Time Factors; Visual Cortex | 2000 |
Cholinergic influence on vestibular stimulation-induced locus coeruleus inhibition in rats.
Topics: Animals; Aziridines; Caloric Tests; Choline; Cholinergic Fibers; Disease Models, Animal; Electrodes, Implanted; Locus Coeruleus; Male; Motion Sickness; Muscarinic Antagonists; Neuromuscular Blocking Agents; Rats; Rats, Sprague-Dawley; Scopolamine; Time Factors; Vestibule, Labyrinth | 2000 |
Effects of selegiline alone or with donepezil on memory impairment in rats.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Aziridines; Behavior, Animal; Choline; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Synergism; Escape Reaction; Fenclonine; Indans; Male; Maze Learning; Memory Disorders; Piperidines; Rats; Rats, Inbred F344; Reaction Time; Scopolamine; Selegiline; Time Factors | 2005 |
Changes in activity of proline-specific peptidases in rat model for dementia of Alzheimer's type.
Topics: Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Aziridines; Cerebral Cortex; Choline; Dipeptidyl Peptidase 4; Hippocampus; Male; Prolyl Oligopeptidases; Rats; Rats, Wistar; Reaction Time; Scopolamine; Serine Endopeptidases; Statistics, Nonparametric | 2012 |